DRUG · COUNSELLING NOTES
Tisagenlecleucel
KYMRIAH
Updated
New prescription
indication: _____. one-time IV infusion; no driving 8 wks; report fever; warned on allergies; serious/common AEs: cytokine release, neurotoxicity, infections; non-pharm: infection precautions.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; one-time IV infusion; no driving 8 wks; report fever; warned on allergies; serious/common AEs: cytokine release, neurotoxicity, infections; non-pharm: infection precautions.